Phase II trial of mitoxantrone in refractory acute leukemia.

Elihu H. Estey(University of Washington), Emil J. Freireich(Unknown), Michael J. Keating(The University of Texas MD Anderson Cancer Center), K. B. McCredie(Penrose Hospital), G. P. Bodey(The University of Texas MD Anderson Cancer Center)

PubMed

April 1, 1983

Cited by 64

Related Papers

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

|Blood|2016|5.9k

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

|Blood|2009|3.4k

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

|Blood|2008|3.2k

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

|Journal of Clinical Oncology|2003|2.7k

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

|Blood|2022|2.7k